Paoli Calmettes Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Paoli Calmettes Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10501
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Paoli Calmettes Institute (IPC) is a cancer treatment institute. The institute provides medical activities such as consultations, imaging examinations, chemotherapy preparations, radiotherapy sessions, surgical stays, endoscopies, and bone marrow and stem cell transplants. Its areas of distinction include oncohaematology, breast cancer, digestive cancers, urologic cancers and gynecological cancers. IPC also provides human, economic and social sciences; technological platforms, transitional medicine, clinical tests, and research and development services. The institute operates operating room rooms, surgical robots and one device of intraoperative radiotherapy. IPC is headquartered in Marseille, France.

Paoli Calmettes Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Paoli Calmettes Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Paoli Calmettes Institute, Medical Devices Deals, 2012 to YTD 2018 9
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 11
Eisai Enters into Research Agreement with Paoli Calmettes Institute 12
Institut Paoli-Calmettes Enters into Research Collaboration with Innate Pharma 13
Equity Offering 14
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 14
Paoli Calmettes Institute – Key Competitors 15
Paoli Calmettes Institute – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Feb 07, 2017: Oncodesign’s OncoSNIPE collaborative programme receives €7.7 million in support from the “Investments for the Future Programme” operated by Bpifrance 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Key Facts 2
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Paoli Calmettes Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Paoli Calmettes Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Paoli Calmettes Institute, Medical Devices Deals, 2012 to YTD 2018 9
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 11
Eisai Enters into Research Agreement with Paoli Calmettes Institute 12
Institut Paoli-Calmettes Enters into Research Collaboration with Innate Pharma 13
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 14
Paoli Calmettes Institute, Key Competitors 15

List of Figures
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Paoli Calmettes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Paoli Calmettes Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Paoli Calmettes Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SOGAZ Insurance Group:企業の戦略・SWOT・財務分析
    SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report Summary SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Seventh Sense Biosystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Seventh Sense Biosystems Inc (Seventh Sense) is a medical device company that designs, develops and markets blood collection devices for use in research and clinical testing applications. The company’s products include testing devices, TAP devices, sterile and microneedle arrays, among other …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Finnish Funding Agency for Innovation-製薬・医療分野:企業M&A・提携分析
    Summary Finnish Funding Agency for Innovation (Tekes) is a financing organization that offers research and technological development programs. The organization offers financial services for research, development and novelty. It provides finance for research and development of new technologies, busin …
  • AIT Austrian Institute of Technology GmbH-医療機器分野:企業M&A・提携分析
    Summary AIT Austrian Institute of Technology GmbH (AIT) is a research and technology institute that provides research development services in various fields. The institute offers research on health and environment, energy, mobility, digital safety and security, and innovation systems. Its health and …
  • KINeSYS Inc.:企業の戦略・SWOT・財務分析
    KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report Summary KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Verdezyne Inc-製薬・医療分野:企業M&A・提携分析
    Summary Verdezyne Inc (Verdezyne) is an industrial biotechnology company that develops and produces chemicals from renewable and non-food sources. The company’s products include adipic acid, dodecanedioic acid and sebacic acid. Its products are used in production of toothbrush bristles and fishing l …
  • Constantia Industries AG:企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Altadis USA Inc:企業の戦略・SWOT・財務情報
    Altadis USA Inc - Strategy, SWOT and Corporate Finance Report Summary Altadis USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Industrial and Commercial Bank of China Ltd:企業のM&A・事業提携・投資動向
    Industrial and Commercial Bank of China Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Industrial and Commercial Bank of China Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • CIBC Wealth Management:企業の戦略・SWOT・財務分析
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Medipines Corp:医療機器:M&Aディール及び事業提携情報
    Summary MediPines Corp (Medipines) is a provider of respiratory measurement technology products. The company develops portable and non-invasive devices based on pulse oximetry technology. The company’s lead product candidate, Oxistimulator, is a respiratory depression prevention device. Its Oxistimu …
  • CPFL Energia SA:企業の発電所・SWOT分析2018
    CPFL Energia SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Rocky Brands Inc (RCKY):企業の財務・戦略的SWOT分析
    Rocky Brands Inc (RCKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pathogenetix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Pathogenetix Inc (Pathogenetix), formerly US Genomics, a subsidiary of Toxic Reports LLC, is a medical device company that develops an automated system for bacterial strain typing from complex samples. The company develops products and applications based on its proprietary genome sequence sc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆